Phage Based Diagnostics

01359 231856

Twitter Youtube Linkedin Envelope
Search
Generic filters

People

Loading...
Tom Green

Tom Green, Chairman
March 10, 2022
Following a career in vertically integrated production agriculture, farming over 85,000 hectares in UK and Europe as CEO of Spearhead International, Tom is now focussing on the theme of ‘Agritech to drive farm performance and sustainability’. Continuing as an NED...
Tom Green

Tom Green, Chairman
March 10, 2022
Following a career in vertically integrated production agriculture, farming over 85,000 hectares in UK and Europe as CEO of Spearhead...
Jane Theaker, CEO, PBD Biotech (c) Chelsea Shoesmith Photography - square

Jane Theaker, Chief Executive Officer
March 10, 2022
Jane Theaker has a strong track record in precision medicine and novel diagnostics technologies. Her experience includes genomics with AstraZeneca and the co-invention of a new quantitative PCR technology. She headed up a team at Qiagen developing diagnostics kits to...
Jane Theaker, CEO, PBD Biotech (c) Chelsea Shoesmith Photography - square

Jane Theaker, Chief Executive Officer
March 10, 2022
Jane Theaker has a strong track record in precision medicine and novel diagnostics technologies. Her experience includes genomics with AstraZeneca...
Cath Rees

Prof Cath Rees, Chief Scientific Officer
March 10, 2022
As Professor in Microbiology at the University of Nottingham, Prof Rees leads research into the applications of bacteriophage against cattle pathogens Mycobacterium paratuberculosis (Johne's disease) and Mycobacterium bovis (bovine TB). This work led to the creation of the Actiphage diagnostic...
Cath Rees

Prof Cath Rees, Chief Scientific Officer
March 10, 2022
As Professor in Microbiology at the University of Nottingham, Prof Rees leads research into the applications of bacteriophage against cattle...
Ben Swift

Dr Ben Swift, Director of Research and Development
March 10, 2022
Ben is currently a Research Fellow in Antimicrobial Resistance at the Royal Veterinary College. His work, in collaboration with Cath Rees led to the creation of the Actiphage diagnostic. He continues to be involved in developing rapid detection methods for...
Ben Swift

Dr Ben Swift, Director of Research and Development
March 10, 2022
Ben is currently a Research Fellow in Antimicrobial Resistance at the Royal Veterinary College. His work, in collaboration with Cath...
Geoff Gower, Operations Director, PBD Biotech

Geoff Gower, Operations Director
March 10, 2022
Geoff has a significant track record in diagnostic manufacturing and joined PBD Biotech to oversee the scale-up of Actiphage from a research to a commercial environment. Geoff has an impressive track-record of building start-ups to become market leaders in their...
Geoff Gower, Operations Director, PBD Biotech

Geoff Gower, Operations Director
March 10, 2022
Geoff has a significant track record in diagnostic manufacturing and joined PBD Biotech to oversee the scale-up of Actiphage from...
Dr Tomas Richardson, R&D Manager

Dr Tomas Richardson, R&D Manager
March 10, 2022
Tomas is a highly cited researcher specialising in the development and optimisation of molecular diagnostic assays. He has previously led the design and validation of multiplex qPCR and RT-qPCR kits for the veterinary diagnostics market and has experience of managing...
Dr Tomas Richardson, R&D Manager

Dr Tomas Richardson, R&D Manager
March 10, 2022
Tomas is a highly cited researcher specialising in the development and optimisation of molecular diagnostic assays. He has previously led...

Dr Berwyn Clarke, co-founder
March 3, 2022
Berwyn is a specialist in personalized medicine, companion diagnostics and the application of novel diagnostics both to central laboratory and point-of-care utilities. He has worked in the pharmaceutical and diagnostics industry for over 30 years occupying senior management positions and...

Dr Berwyn Clarke, co-founder
March 3, 2022
Berwyn is a specialist in personalized medicine, companion diagnostics and the application of novel diagnostics both to central laboratory and...

Dr Luis Martin, Managing Director, PBD Biotech Canada
March 3, 2022
Luis heads up PBD Biotech’s Canadian headquarters in Saskatoon. The company, in collaboration with industry and academic partners, is currently validating the use of Actiphage for cattle and for other species, such as bison, elk and deer, that are also...

Dr Luis Martin, Managing Director, PBD Biotech Canada
March 3, 2022
Luis heads up PBD Biotech’s Canadian headquarters in Saskatoon. The company, in collaboration with industry and academic partners, is currently...

Bob Lyons, Director/North America
March 3, 2022
Bob leads PBD Biotech’s efforts in the U.S. in the business, outreach, strategic alliance and management domains. He is an early member of PBD and has connected the company into the mainline US agencies such as the USDA and NIH...

Bob Lyons, Director/North America
March 3, 2022
Bob leads PBD Biotech’s efforts in the U.S. in the business, outreach, strategic alliance and management domains. He is an...

Tom Kellner, Director of Operations/North America
March 3, 2022
Originally a veterinary scientist, Tom has a strong track record in diagnostics and animal health and has been involved in TB and Johne’s testing for fifteen years, including licensing the AsureQuality skin test tuberculin in the USA. Tom has joined...

Tom Kellner, Director of Operations/North America
March 3, 2022
Originally a veterinary scientist, Tom has a strong track record in diagnostics and animal health and has been involved in...

developers of phage-based diagnostics

Contact Us

PBD Biotech Ltd
Link House, Elm Farm Park,
Great Green, Thurston,
Suffolk IP31 3SH,
United Kingdom

Registered Company Address
Ingenuity Centre,
University of Nottingham,
Innovation Park, Triumph Rd,
Nottingham NG7 2TU,
United Kingdom

T: 01359 231856
info@pbdbio.com

Privacy and cookies policy

© 2022 PBD Biotech Ltd

design: out of house